Novavax Covid vaccine nearly 90% effective in UK trial – video
by from World news | The Guardian on (#5DFP8)
Another Covid vaccine, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus.
Stanley Erck, CEO of Novavax, has said numbers show dramatic demonstrations' of the new vaccine's ability to develop an immune response against different strains of Covid-19.
The UK vaccines taskforce has bought 60m doses of the Novavax vaccine which will be manufactured on Teesside in the UK
- Novavax Covid vaccine shown to be nearly 90% effective in UK trial
- Coronavirus - latest updates
- See all our coronavirus coverage